The global softgel capsules market was valued at USD 8.5 billion in 2025 and is expected to reach USD 9.1 billion in 2026, before expanding to USD 15.4 billion by 2033. This represents a 7.9% CAGR from 2026 to 2033. North America led the market in 2025 with a 41.2% global revenue share, while Asia Pacific is expected to register the fastest growth during the forecast period.

Market Snapshot

Key Market Trends & Insights

• Type: Gelatin-based/animal-based softgel capsules accounted for the largest share at 83.4% in 2025.
• Application: Vitamin and dietary supplements represented the leading application segment, with a 23.2% share in 2025.
• End Use: Pharmaceutical companies accounted for the largest end-use share at 51.8% in 2025.
• Regional leadership: North America held the largest regional share, representing 41.2% of global revenue in 2025.
• Regional growth: Asia Pacific is projected to experience the highest CAGR from 2026 to 2033.
• Country leadership: The U.S. accounted for the largest share of the North American market in 2025.

Download a free sample report or claim your copy of this full market intelligence report

What Is Driving Softgel Capsules Market Growth?

Growing consumption of dietary supplements, preventive healthcare products, and specialty oral formulations is increasing demand for softgel capsules across developed and emerging economies. Their ability to provide accurate dosing, formulation stability, and convenient oral administration makes them suitable for a wide range of pharmaceutical and nutraceutical products.

The growing popularity of vitamins, minerals, omega-3 supplements, herbal formulations, and other functional nutrition products is creating additional opportunities for softgel manufacturers. Pharmaceutical companies are also increasingly adopting softgel dosage forms for active pharmaceutical ingredients that may benefit from improved absorption and bioavailability.

Another important factor is the expansion of contract development and manufacturing organizations (CDMOs). Pharmaceutical and consumer healthcare companies are outsourcing more manufacturing activities, encouraging CDMOs to expand production capacity and invest in advanced encapsulation equipment.

Manufacturing Innovation and Emerging Opportunities

Softgel manufacturers are investing in advanced encapsulation technologies, production automation, and alternative capsule materials to improve operational efficiency and respond to evolving consumer preferences. Interest in vegetarian and plant-based capsule materials is also expanding formulation options beyond conventional gelatin-based products.

The expansion of e-commerce healthcare distribution, broader healthcare access, and continued innovation in pharmaceutical and consumer health products are further supporting market development. These factors are contributing to demand across major regional markets and creating opportunities for manufacturers to diversify their product offerings.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Market Dynamics

Driver: Rising Demand for Nutraceuticals and Advanced Oral Dosage Forms

The increasing consumption of dietary supplements, functional nutrition products, and pharmaceutical formulations is a major growth driver for the softgel capsules market. Softgels are particularly suitable for lipid-based ingredients, including omega-3 fatty acids, fat-soluble vitamins, coenzyme Q10, permitted cannabidiol formulations, and botanical extracts.

The dosage form can help provide consistent dosing, protection of sensitive ingredients, and convenient administration, making it attractive for both consumers and pharmaceutical manufacturers. Softgels are also being used for poorly water-soluble active pharmaceutical ingredients where formulation strategies may improve absorption.

The increasing focus on preventive healthcare and self-medication, together with consumer demand for convenient oral dosage forms, continues to support market expansion. Meanwhile, outsourcing to CDMOs is encouraging investment in manufacturing infrastructure and encapsulation capabilities.

For example, in October 2025, Lonza Capsugel launched Organicaps capsules, described as USDA organic-certified, plant-based immediate-release pullulan capsules manufactured in North America. The product was introduced for organic supplement manufacturers and was positioned around oxygen-barrier performance, polymer stability, and compatibility with organic formulations.

Competitive Landscape

The softgel capsules industry includes pharmaceutical manufacturers, contract manufacturers, capsule specialists, and healthcare companies. Key companies identified in the market include:

• Fuji Capsule
• Sirio Pharma Co., Ltd.
• CAPTEK Softgel International Inc.
• Thermo Fisher Scientific Inc.
• EyePoint Pharmaceuticals, Inc.
• Catalent, Inc.
• EuroCaps

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• S. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.